KPV Shows Anti-Inflammatory Activity in Murine Models of Intestinal Inflammation
Kannengiesser et al. (2008) evaluated the melanocortin-derived tripeptide KPV in two established murine models of inflammatory bowel disease: DSS colitis and CD45RBhi transfer colitis. The investigators found that KPV reduced histologic inflammation and improved inflammatory readouts in vivo. Importantly, the work suggested that the anti-inflammatory activity of KPV could be retained even in systems where classical melanocortin receptor signaling was limited, supporting the idea that the minimal tripeptide motif itself may carry biologically relevant anti-inflammatory properties. This study helped establish KPV as a compact pharmacophore of α-MSH-related peptide research.
Citation: Kannengiesser K, Maaser C, Heidemann J, Luegering A, Ross M, Brzoska T, Bohm M, Luger TA, Domschke W, Kucharzik T. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-331. doi:10.1002/ibd.20334. PubMed PMID: 18092346
PepT1-Mediated KPV Uptake Reduces Intestinal Inflammation
Dalmasso et al. (2008) demonstrated that KPV is transported into cells by the peptide transporter PepT1 and that this uptake is functionally linked to anti-inflammatory activity. In human intestinal epithelial cells and Jurkat T cells, nanomolar concentrations of KPV inhibited NF-κB and MAP kinase inflammatory signaling while reducing pro-inflammatory cytokine secretion. In mouse DSS and TNBS colitis models, oral KPV administration reduced inflammatory burden and cytokine expression. This study was especially important because it connected KPV activity to a defined uptake mechanism, supporting its relevance for epithelial and mucosal peptide research.
Citation: Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. doi:10.1053/j.gastro.2007.10.026. PubMed PMID: 18061177
KPV Signaling in Human Keratinocyte Models
Elliott et al. (2004) examined α-MSH, KPV, and related peptides in human keratinocyte systems to better understand how the minimal anti-inflammatory tripeptide motif signals at the cellular level. The authors reported that KPV and related short melanocortin peptides could trigger intracellular calcium responses in keratinocyte models without producing the classic cyclic AMP response generally associated with MC1R signaling. These findings suggested that KPV-related biology may extend beyond a simple miniature mimic of full-length α-MSH and may involve alternative signaling behavior relevant to skin and epithelial peptide research.
Citation: Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, Haycock JW. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol. 2004;122(4):1010-1019. doi:10.1111/j.0022-202X.2004.22404.x. PubMed PMID: 15102092
Alpha-MSH Related Peptides as a New Class of Anti-Inflammatory and Immunomodulating Agents
Luger and Brzoska (2007) reviewed the growing body of literature showing that α-MSH-related peptides modulate inflammatory responses through effects on NF-κB activation, adhesion molecules, chemokine receptors, and cytokine production. A central conclusion of the review was that many of the anti-inflammatory activities attributed to α-MSH can be localized to its C-terminal tripeptide KPV. The paper also highlighted K(D)PT, a derivative related to KPV, as an emerging anti-inflammatory tripeptide. For proprietary KPV-based combinations such as KLOW, this review provides an important conceptual bridge from the full melanocortin peptide family to minimal anti-inflammatory motifs.
Citation: Luger TA, Brzoska T. alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs. Ann Rheum Dis. 2007;66 Suppl 3(Suppl 3):iii52-iii55. doi:10.1136/ard.2007.079780. PubMed PMID: 17934097
Broad Review of Alpha-MSH and Related Tripeptides in Immune-Mediated Inflammation
Brzoska et al. (2008) published a wide-ranging review of α-MSH and related tripeptides, summarizing their anti-inflammatory and protective effects across multiple in vitro and in vivo systems. The review described actions on NF-κB activity, adhesion molecules, chemokine receptor expression, cytokine production, IL-10 synthesis, inflammatory cell migration, oxidative stress response, and apoptosis. It also emphasized that the small tripeptide motifs derived from α-MSH retain meaningful biological activity despite their minimal size. This literature provides the broader scientific context for KPV-centered blend research in epithelial, immune, and barrier-focused models.
Citation: Brzoska T, Luger TA, Maaser C, Abels C, Bohm M. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev. 2008;29(5):581-602. doi:10.1210/er.2007-0027. PubMed PMID: 18612139
Reviewed for scientific accuracy — Chameleon Peptides Research Team. Last reviewed: March 2026.